Neuralink
The vision-restoring device will be implanted in humans within six to 12 months, following a successful monkey implantation that has remained active for three years, Musk said.
Brad Smith is the third person in the world to receive Neuralink's brain-computer implant and the first person with ALS.
Musk says the implant will initially provide blind individuals with low-resolution sight with the potential for superhuman vision in the future.
The terms align with the company's brain-computer interface technologies aimed at restoring vision and enabling mind-controlled device use.
Musk revealed on X that the SEC has reopened its investigation into Neuralink, sharing a letter from his attorney addressed to the commission's chair.
The announcement comes about four months after Musk relayed his vision for patients with an Optimus robotic arm or leg to have the ability to control their limbs with the N1 implant.
Elon Musk's Neuralink gets greenlit by Health Canada to perform the first trial outside of the U.S. of its brain-computer implant and robot technology.
Blindsight is an experimental implant aimed at restoring vision in individuals who have lost sight in both eyes.
Also: Abbott sells 150 million of its rapid, app-paired COVID-19 test to the White House; Platform launches for chronic disease patients juggling multiple providers.